Veracyte joins Bay Area life sciences IPO parade

Shares of freshly public medical diagnostics company Veracyte Inc. rose from their $13 debut price early Wednesday after the company’s IPO raised $65 million...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.